Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki

被引：6
|
作者：
Chiyoda, S [1 ]
Kinoshita, K [1 ]
Egawa, S [1 ]
Inoue, J [1 ]
Watanabe, K [1 ]
Ifuku, M [1 ]
机构：
[1] Nagasaki Red Cross, Blood Ctr, Nagasaki 8528145, Japan
来源：
INTERNAL MEDICINE | 2001年 / 40卷 / 01期
关键词：
breast feeding; adult T-cell leukemia;
D O I：
10.2169/internalmedicine.40.14
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective The aim of this study was to clarify the trend of the HTLV-1 seroprevalence rate among blood donors. Methods Samples were screened by the particle agglutination test for HTLV-1 antibodies. Materials Serum from blood donors was screened. Results The positive rate of HTLV-1 antibodies among blood donors decreased from 13.14 to 0.81% over the years from 1928 to 1983. Conclusion A decline over the years in the positive rate of HTLV-1 antibodies among blood donors was revealed.
引用
收藏
页码：14 / 17
页数：4
相关论文
共 50 条
  • [21] Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria
    Okoye, Augustine Ejike
    Ibegbulam, Obike Godswill
    Onoh, Robinson Chukwudi
    Ugwu, Ngozi Immaculata
    Anigbo, Chukwudi Simon
    Nonyelu, Charles Emeka
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 31 - 36
  • [22] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Santos, Rilma F. S.
    Conceicao, Gildasio C.
    Martins, Marcia S.
    Kraychete, Angiolina
    Penalva, Maria A. C.
    Carvalho, Edgar M.
    Lopes, Antonio Alberto
    Rocha, Paulo Novis
    BMC NEPHROLOGY, 2017, 18
  • [23] Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient
    Waziri, A
    Soldan, SS
    Graf, MD
    Nagle, J
    Jacobson, S
    JOURNAL OF VIROLOGY, 2000, 74 (05) : 2178 - 2185
  • [24] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Rilma F. S. Santos
    Gildásio C. Conceição
    Márcia S. Martins
    Angiolina Kraychete
    Maria A. C. Penalva
    Edgar M. Carvalho
    Antonio Alberto Lopes
    Paulo Novis Rocha
    BMC Nephrology, 18
  • [25] HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 UVEITIS
    MOCHIZUKI, M
    TAJIMA, K
    WATANABE, T
    YAMAGUCHI, K
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (02) : 149 - 154
  • [26] Prevalence of Human T-lymphotropic Virus Type 1 (HTLV-1) Infection in Patients with Different Etiologies
    Ghaffari, Javad
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (06) : 353 - 353
  • [27] Recurrent facial palsy revealing Human T-lymphotropic virus type 1 (HTLV-1) infection
    Leclercq, M.
    Sauvetre, G.
    Levesque, H.
    Marie, I.
    REVUE DE MEDECINE INTERNE, 2015, 36 (10): : 701 - 705
  • [28] Human T-Lymphotropic Virus Type 1 (Htlv-1): a new subgroup within the cosmopolitan subtype
    María Eirin
    Leandro Jones
    Carolina Berini
    Darío Dilernia
    Cecilia Delfino
    Mirna Biglione
    Retrovirology, 8 (Suppl 1)
  • [29] Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
    Araya, Natsumi
    Sato, Tomoo
    Yagishita, Naoko
    Ando, Hitoshi
    Utsunomiya, Atae
    Jacobson, Steven
    Yamano, Yoshihisa
    VIRUSES-BASEL, 2011, 3 (09): : 1532 - 1548
  • [30] Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo
    Ghezeldasht, Sanaz Ahmadi
    Bidkhori, Hamid Reza
    Miri, Raheleh
    Baghban, Arezoo
    Mosavat, Arman
    Rezaee, Seyed Abdolrahim
    JOURNAL OF NEUROVIROLOGY, 2023, 31 (1) : 24 - 34
12345